Overview

The interstitial lung diseases (ILD) are a complex group of diagnoses that require specialized care provided by an interdisciplinary team that includes pulmonologists, chest radiologists, and lung pathologists. The most common ILD, idiopathic pulmonary fibrosis (IPF), is a progressive disease with an unpredictable course characterized by irreversible, and ultimately fatal, scarring of the lungs.

The IPF ECHO seeks to provide greater access to the knowledge of pulmonary specialists in both rural and urban areas.  Providers and their peers will have the opportunity to present real life cases and receive feedback from a multidisciplinary team of experts. In addition, they can look forward to hearing the latest in clinical trends from leading experts in the field of idiopathic pulmonary fibrosis.

Case review is an important part of medical education and will now be available to individuals outside a single institution. Project ECHO will leverage these traditional sessions so that more care providers from across the Mountain region have access to a multidisciplinary panel review. 

Cases will be selected from submitted forms to provide optimal educational value. Each Echo will start with a didactic presentation from a specialist to provide further insight into diagnosis and care management of IPF patients. 

Sessions will be hosted by Dr. Mary Beth Scholand, associate professor in pulmonary medicine. She is currently the director of the Interstitial Lung Disease Clinic at University of Utah Health and center director for the Utah Pulmonary Fibrosis Foundation Care Center Network site.

ABIM MOC Medical Knowledge Assessment credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

If you are interested in learning more please contact:

Lisa Weaver
Clinical Research Manager
Email: lisa.weaver@hsc.utah.edu

Clinic Times

Selected Fridays @ 10:30 am MT

Clinical Team

Mary Beth Scholand, MD
Associate Professor, Pulmonary Division
Director ILD Clinic

Tracy Frech, MD
Associate Professer, Rheumatology
Director of Systemic Sclerosis Clinic

Barbara Cahill, MD
Medical Director of Lung Transplant

Sanjeev Raman, MD
Assistant Professor
Respiratory, Critical Care, and Occupational Pulmonary Medicine

Debra Wahlquist, APRN
Pulmonary

Lisa Weaver
Clinical Research Manager
Email: lisa.weaver@hsc.utah.edu

 

Forms

Coming soon...

Resources

Coming soon...

Clinical Updates

ECHO Date

Clinical Update Title Slides
January 27, 2017 "Up to the Minute in IPF" - Dr. Mary Beth Scholand
February 10, 2017
March 17, 2017 "Pharmacotherapies in IPF" - Holly Ann Jacobs, PharmD
April 21, 2017 "Rheumatologic and other Collagen Vascular Disease as Relates to IPF" - Dr. Tracy Frech
May 19, 2017 "Lung Transplant in the IPF Patient" - Dr. Sanjeev M. Raman
June 16, 2017 "Palliative Care in IPF" - Dr. Nathan Wanner
July 14, 2017
August 18, 2017 "Transplant in the IPF Patient" - Dr. Barbara Cahill
September 15, 2017
October 20, 2017
November 17, 2017

 

Sessions yet to be scheduled
"Role of HRCT" - University of Utah Chest Radiology Team
"Supporting Therapies - Pulmonary Rehab, Oxygen Therapy, Cough" - Dr. Mary Beth Scholand
"Significance and Frequency of GERD in IPF" - Dr. Mary Beth Scholand
"Primary Care Physicians and IPF" - Dr. Mary Beth Scholand
"Sleep Management in the IPF Patient" - Dr. Krishna Sundar
"Updates in Clinical Research in IPF" - Dr. Mary Beth Scholand

Videos

Coming soon...